AI Verdict
LIFX has stronger fundamentals based on our AI analysis.
LIFX vs LIANY Fundamental Comparison
| Metric | LIFX | LIANY |
|---|---|---|
| Revenue | $489.5M | $7.9M |
| Net Income | $150.8M | $-69.7M |
| Net Margin | 30.8% | -886.0% |
| ROE | 27.5% | -34.4% |
| ROA | 15.7% | -26.5% |
| Current Ratio | 6.26x | 10.06x |
| Debt/Equity | 0.01x | 0.00x |
| EPS | $1.77 | $-0.65 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LIFX vs LIANY: Frequently Asked Questions
Is LIFX or LIANY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LIFX has stronger fundamentals. LIFX is rated BUY (72% confidence) while LIANY is rated SELL (72% confidence). This is not investment advice.
How does LIFX compare to LIANY fundamentally?
Life360, Inc. has ROE of 27.5% vs LianBio's -34.4%. Net margins are 30.8% vs -886.0% respectively.
Which stock pays higher dividends, LIFX or LIANY?
LIFX has a dividend yield of N/A or no dividend while LIANY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LIFX or LIANY for long term?
For long-term investing, consider that LIFX has BUY rating with 72% confidence, while LIANY has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LIFX vs LIANY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LIFX vs LIANY, the AI consensus favors LIFX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.